Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Mouth Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2 Uterine Cervical Neoplasms 1 Sentinel Lymph Node Biopsy (SLNB) 1 Sarcoidosis, Pulmonary 1 Sarcoidosis 1 Rhabdomyosarcoma 1 Recurrence 1 Recurent Vulvar Carcinoma 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Melanoma 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 HIV Infections 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1 Eyelid Sebaceous Gland Carcinoma 1 Cervical Adenocarcinoma 1 Carcinoma, Ductal 1 Anus Neoplasms 1

Interventions

Cyclophosphamide 51 fludarabine 37 Dexamethasone 35 venetoclax 30 pembrolizumab 25 Rituximab 20 pomalidomide 18 Lenalidomide 17 Gemcitabine 17 fludarabine phosphate 15 Etoposide 14 Cytarabine 13 daratumumab 12 carfilzomib 11 Temozolomide 11 Injections 10 Calcium Dobesilate 10 glofitamab 9 Nivolumab 9 Cisplatin 9 Bortezomib 9 Azacitidine 9 selinexor 8 Vincristine 8 Immunotherapy, Adoptive 8 obinutuzumab 7 cemiplimab 7 Drug Therapy 7 Carboplatin 7 zanubrutinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Sentinel Lymph Node Biopsy × 1 year × Clear all

NCT03719547 2025-07-01

RACC

Karolinska Institutet

Phase NA Recruiting

Uterine Cervical Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡